Masakazu Yashiro

45PUBLICATIONS
28CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Sep 26, 2026
The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants.

|Jul 27, 2026
Deep Learning on H&E Pathology Images Predicts KRAS and TP53 Mutations in Pancreatic Adenocarcinoma: A Multicenter Study.

|May 04, 2026
Pan-Cancer Prediction of Genomic Alterations from H&E Whole-Slide Images in a Real-World Clinical Cohort.

|Apr 17, 2026
Extensive intraoperative peritoneal lavage (EIPL) for gastric cancer with positive peritoneal lavage and/or stamp cytology: An exploratory phase II study.

|Feb 26, 2026
The Significance of the Heterogeneity of Cancer-Associated Fibroblasts in Tumor Microenvironments.

Daiki Imanishi, Hinano Nishikubo, Dongheng Ma

|Jan 28, 2026
Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777.

Hinano Nishikubo, Dongheng Ma, Tomoya Sano

Pageof 8

Frequent Collaborators

5 joint publications

Hinano Nishikubo

4 joint publications

Tasuku Matsuoka

3 joint publications

Canfeng Fan

2 joint publications

Dongheng Ma